These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26050586)

  • 1. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.
    Chung C; Metser U; Ménard C
    Semin Radiat Oncol; 2015 Jul; 25(3):164-71. PubMed ID: 26050586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
    Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
    Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.
    Kim MM; Lawrence TS; Cao Y
    Semin Radiat Oncol; 2015 Jul; 25(3):172-80. PubMed ID: 26050587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of (18)F-fluoroethyl-L: -tyrosine PET and magnetic resonance diffusion tensor imaging.
    Stadlbauer A; Pölking E; Prante O; Nimsky C; Buchfelder M; Kuwert T; Linke R; Doelken M; Ganslandt O
    Acta Neurochir (Wien); 2009 Sep; 151(9):1061-9. PubMed ID: 19468675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma grading by dynamic susceptibility contrast perfusion and
    Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Reischl G; Bender B; Ernemann U; la Fougère C; Klose U
    Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.
    Rapp M; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Galldiks N
    Neurosurg Focus; 2013 Feb; 34(2):E3. PubMed ID: 23373448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
    Galldiks N; Langen KJ
    Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography of high-grade gliomas.
    Frosina G
    J Neurooncol; 2016 May; 127(3):415-25. PubMed ID: 26897013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
    Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
    J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.
    Neill E; Luks T; Dayal M; Phillips JJ; Perry A; Jalbert LE; Cha S; Molinaro A; Chang SM; Nelson SJ
    J Neurooncol; 2017 Mar; 132(1):171-179. PubMed ID: 28124178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroimaging in brain tumors].
    Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
    Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma.
    García Vicente AM; Jiménez Aragón F; Villena Martín M; Jiménez Londoño GA; Borrás Moreno JM
    Clin Nucl Med; 2017 Jun; 42(6):e300-e303. PubMed ID: 28319501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
    Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
    Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lucas JT; Serrano N; Kim H; Li X; Snyder SE; Hwang S; Li Y; Hua CH; Broniscer A; Merchant TE; Shulkin BL
    J Neurooncol; 2017 Mar; 132(1):163-170. PubMed ID: 28078638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Evaluation of Glioma.
    Mohammadzadeh A; Mohammadzadeh V; Kooraki S; Sotoudeh H; Kadivar S; Shakiba M; Rasuli B; Borhani A; Mohammadzadeh M
    Neuroimaging Clin N Am; 2016 Nov; 26(4):567-580. PubMed ID: 27712794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.